PATH EX: Funding, Investors & Team (Oct 2026)
PATH EX has developed a unique technology that can selectively extract bacteria and toxins from human blood to treat sepsis, a life-threatening condition caused by a blood-borne infection. This condition is the leading cause of death in intensive care units and places a significant financial burden on the healthcare system. Unlike traditional methods that rely on broad spectrum antibiotics to kill the infection, PATH EX's approach involves capturing intact bacteria from the blood. This technology is effective against all types of bacteria and drug resistance. By potentially reducing diagnostic times, treatment expenses, readmission rates, and sepsis-related fatalities, PATH EX's technology offers promising benefits.
PATH EX has raised $5.0M across 1 funding round on record, the most recent an undisclosed round of $5.0M announced in May 2025.
That round is in line with the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
PATH EX Company Profile and Key Stats
Latest funding round on record: May 2025.
PATH EX Funding Rounds
PATH EX Founders and Leadership Team
Contact details for the PATH EX team: 1 of 1 has an email address on file.
Start 14-day free trial →PATH EX Funding Compared to Other Health Care Startups
PATH EX's latest round of $5.0M is in line with the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PATH EX in Health Care and Nashville
Companies Similar to PATH EX
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
PATH EX Funding FAQs
What does PATH EX do?
PATH EX has developed a unique technology that can selectively extract bacteria and toxins from human blood to treat sepsis, a life-threatening condition caused by a blood-borne infection. This condition is the leading cause of death in intensive care units and places a significant financial burden on the healthcare system. Unlike traditional methods that rely on broad spectrum antibiotics to kill the infection, PATH EX's approach involves capturing intact bacteria from the blood. This technology is effective against all types of bacteria and drug resistance. By potentially reducing diagnostic times, treatment expenses, readmission rates, and sepsis-related fatalities, PATH EX's technology offers promising benefits.
How much funding has PATH EX raised?
PATH EX has raised $5.0M across 1 round on record. The most recent is an undisclosed round of $5.0M announced in May 2025.
When did PATH EX last raise funding?
PATH EX's most recent funding round on record is an undisclosed round of $5.0M, announced in May 2025.
Who founded PATH EX?
FundedIQ lists Sinead Miller (Founder) at PATH EX.
Where is PATH EX headquartered?
PATH EX is based in Nashville, Tennessee, United States.
How many employees does PATH EX have?
PATH EX is in the 1-10 employee band.
How does PATH EX's funding compare to other Health Care startups?
PATH EX's latest round of $5.0M is in line with the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's PATH EX Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PATH EX is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.